James Flaherty, MD
Surgical Oncology · New Britain, CTNPI 1518071513
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,675 of the $9,791 with a category attached, or 88.6%. Intuitive Surgical accounts for 97.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $5,587 and has fallen 98.4% since, to $87 in 2025.
Across 25 payments — averaging $391.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Takeda Pharmaceuticals U.S.A., Inc.$74
- Merck$59
- TELA Bio, Inc.$28
- Johnson & Johnson$27
- Shire North American Group Inc$21
- plus $52 from 3 others
What the payments were for
- Travel & lodging$8088%
- Food & beverage$3083%
- Education$8,67589%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 14 | $9,531 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Merck | 2 | $59 |
| TELA Bio, Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $27 |
| Shire North American Group Inc | 1 | $21 |
| Kerecis Limited | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Conmed Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$8,500
- Da Vinci Surgical System$915
How this compares
$9,791 in reported general payments places this provider in the 85th percentile of 30 surgical oncology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in New Britain
- Jonathan LewisWestport$115K
- Isaac KimNew Haven$35K
- Bret SchipperHartford$15K
- Helen PassStamford$11K
- Kevin BillingsleyNew Haven$6K
- Csaba GajdosStamford$5K
- Swagoto MukhopadhyayFarmington$4K
- Ramanathan Madras SeshadriDanbury$4K
- Vera HendrixNew Haven$3K
- John KunstmanNew Haven$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.